Bank of Nova Scotia’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516K | Sell |
9,381
-3,652
| -28% | -$201K | ﹤0.01% | 827 |
|
|
2025
Q1 | $921K | Sell |
13,033
-2,474
| -16% | -$175K | ﹤0.01% | 739 |
|
|
2024
Q4 | $1.02M | Buy |
15,507
+2,083
| +16% | +$137K | ﹤0.01% | 769 |
|
|
2024
Q3 | $944K | Sell |
13,424
-580
| -4% | -$40.8K | ﹤0.01% | 761 |
|
|
2024
Q2 | $1.15M | Sell |
14,004
-139,978
| -91% | -$11.5M | ﹤0.01% | 743 |
|
|
2024
Q1 | $13.4M | Sell |
153,982
-123,486
| -45% | -$10.8M | 0.03% | 344 |
|
|
2023
Q4 | $26.8M | Buy |
277,468
+4,611
| +2% | +$445K | 0.05% | 256 |
|
|
2023
Q3 | $24.1M | Buy |
272,857
+145,685
| +115% | +$12.9M | 0.06% | 205 |
|
|
2023
Q2 | $11M | Buy |
127,172
+24
| +0% | +$2.08K | 0.03% | 272 |
|
|
2023
Q1 | $12.4M | Sell |
127,148
-88,901
| -41% | -$8.64M | 0.04% | 249 |
|
|
2022
Q4 | $22.4M | Buy |
216,049
+211,797
| +4,981% | +$21.9M | 0.06% | 222 |
|
|
2022
Q3 | $360K | Sell |
4,252
-416
| -9% | -$35.2K | ﹤0.01% | 1013 |
|
|
2022
Q2 | $399K | Sell |
4,668
-1,238
| -21% | -$106K | ﹤0.01% | 1025 |
|
|
2022
Q1 | $455K | Buy |
5,906
+2,311
| +64% | +$178K | ﹤0.01% | 1052 |
|
|
2021
Q4 | $320K | Buy |
+3,595
| New | +$320K | ﹤0.01% | 1105 |
|
|
2019
Q4 | – | Sell |
-83,902
| Closed | -$5.66M | – | 912 |
|
|
2019
Q3 | $5.66M | Buy |
+83,902
| New | +$5.66M | 0.02% | 475 |
|